A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer

Charles X. Wang, Guillaume Luxardi, Hidetoshi Mori, Emanual M. Maverakis, Alexander A. Merleev, Alina I. Marusina, Alexander D. Borowsky, Mamta Parikh, Jonathan W. Riess, Ala Moshiri, Lyudmila Bazhenova, Matthew Gubens, Marianna Koczywas, Joseph D. Butner, Jonathan Huang, Soo Kyoung Kim, Logan V. Vick, Yaohui Sun, Robert J. Canter, William J. Murphy, Megan E. Daly, Karen Kelly, Arta M. Monjazeb

Open source

DOI: 10.1080/2162402x.2026.2695491
Published: 2026-09-02
Container: OncoImmunology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/2162402x.2026.2695491,
  title = {A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer},
  author = {Charles X. Wang and Guillaume Luxardi and Hidetoshi Mori and Emanual M. Maverakis and Alexander A. Merleev and Alina I. Marusina and Alexander D. Borowsky and Mamta Parikh and Jonathan W. Riess and Ala Moshiri and Lyudmila Bazhenova and Matthew Gubens and Marianna Koczywas and Joseph D. Butner and Jonathan Huang and Soo Kyoung Kim and Logan V. Vick and Yaohui Sun and Robert J. Canter and William J. Murphy and Megan E. Daly and Karen Kelly and Arta M. Monjazeb},
  year = {2026},
  journal = {OncoImmunology},
  doi = {10.1080/2162402x.2026.2695491},
  url = {https://doi.org/10.1080/2162402x.2026.2695491}
}

RIS

TY  - JOUR
TI  - A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer
AU  - Charles X. Wang
AU  - Guillaume Luxardi
AU  - Hidetoshi Mori
AU  - Emanual M. Maverakis
AU  - Alexander A. Merleev
AU  - Alina I. Marusina
AU  - Alexander D. Borowsky
AU  - Mamta Parikh
AU  - Jonathan W. Riess
AU  - Ala Moshiri
AU  - Lyudmila Bazhenova
AU  - Matthew Gubens
AU  - Marianna Koczywas
AU  - Joseph D. Butner
AU  - Jonathan Huang
AU  - Soo Kyoung Kim
AU  - Logan V. Vick
AU  - Yaohui Sun
AU  - Robert J. Canter
AU  - William J. Murphy
AU  - Megan E. Daly
AU  - Karen Kelly
AU  - Arta M. Monjazeb
PY  - 2026
JO  - OncoImmunology
DO  - 10.1080/2162402x.2026.2695491
UR  - https://doi.org/10.1080/2162402x.2026.2695491
ER  -

APA

Wang, C. X., Luxardi, G., Mori, H., Maverakis, E. M., Merleev, A. A., Marusina, A. I., Borowsky, A. D., Parikh, M., Riess, J. W., Moshiri, A., Bazhenova, L., Gubens, M., Koczywas, M., Butner, J. D., Huang, J., Kim, S. K., Vick, L. V., Sun, Y., Canter, R. J., Murphy, W. J., Daly, M. E., Kelly, K., & Monjazeb, A. M. (2026). A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer. OncoImmunology. https://doi.org/10.1080/2162402x.2026.2695491

Source records

crossref · retrieved 2026-11-10T13:50:49.626Z